The safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients

Author： Wilson Stephen J   Bellamy Mark C   Giannoudis Peter V  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 557-570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant activated Factor VII in major surgery and trauma patients: a response

By Zakhary Randa Grob   Seremetis Stephanie  

Expert Opinion on Drug Safety, Vol. 4, Iss. 5, 2005-09 ,pp. : 813-814

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of albumin administration in trauma

By Chalidis Byron   Kanakaris Nikolaos   Giannoudis Peter V  

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 407-415

Informa Healthcare

Access to resources Recommend Favorite

Eptacog-alfa [activated recombinant factor VII] is an effective, well-tolerated therapy in haemophilia patients with inhibitors

By  

Inpharma, Vol. 1, Iss. 1572, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Determinants of Drug Costs in Hospitalised Patients with Haemophilia: Impact of Recombinant Activated Factor VII

By Galanaud J.P.  

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 699-707

Adis International

Access to resources Recommend Favorite

Management of bleeding emergencies: when to use recombinant activated Factor VII

By DeLoughery Thomas G  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 1, 2006-01 ,pp. : 25-34

Informa Healthcare

Access to resources Recommend Favorite